Nxera Pharma Co., Ltd. (TYO:4565)
Japan flag Japan · Delayed Price · Currency is JPY
1,680.00
-65.00 (-3.72%)
Nov 18, 2026, 10:40 AM JST

Nxera Pharma Financials Overview

Millions JPY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
35,50929,61528,83512,76615,56917,712
Revenue Growth
23.72%2.71%125.87%-18.00%-12.10%100.32%
Gross Profit
29,18821,41721,2199,66414,64316,779
Operating Income
617-8,269-6,624-10,3992,8126,910
Net Income
-5,393-12,530-4,838-7,1933821,017
Earnings Per Share
-59.39-138.80-53.92-87.184.6312.40
EPS Growth
-----62.66%-33.30%

Revenue by Geography

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
Japan
17,96714,0586,17380-22
United States of America
4,8867,9501,3739,93413,937
Bermuda
1,4051,1601,2122,849301
Switzerland
2,1692,1904,0042,5642,311
United Kingdom
1,77369641421,178
Others
74----
Germany
1,3402,781---
Total
29,61428,83512,76615,56917,712

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
16,61320,36536,20349,06566,55760,087
Total Debt
51,95757,37967,90073,97329,73429,271
Net Cash (Debt)
-35,344-37,014-31,697-24,90836,82330,816
Net Cash Growth
----19.49%31.78%
Net Cash Per Share
-389.16-410.01-353.24-301.85445.85375.78

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
5,603-2,668-7,718-5,2739,9527,095
Capital Expenditures
-590-448-526-804-277-193
Free Cash Flow
5,013-3,116-8,244-6,0779,6756,902
Free Cash Flow Growth
----40.18%50.70%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
82.20%72.32%73.59%75.70%94.05%94.73%
Operating Margin
1.74%-27.92%-22.97%-81.46%18.06%39.01%
Pretax Margin
-15.62%-50.48%-16.17%-83.66%6.92%2.44%
Profit Margin
-15.19%-42.31%-16.78%-56.34%2.45%5.74%
FCF Margin
14.12%-10.52%-28.59%-47.60%62.14%38.97%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
----458.51152.62
Forward PE
32.1014.8848.7562.5162.9837.67
P/FCF Ratio
31.81---18.1022.49
PS Ratio
4.492.533.279.9611.258.76